Item 3.01 Notice of Delisting or Failure to Satisfy a
Continued Listing Rule or Standard; Transfer of Listing.

On December 20, 2012, Anthera Pharmaceuticals, Inc. ("Anthera") received a letter from The Nasdaq Stock Market informing Anthera that for the last 30 consecutive business days the bid price of Anthera's common stock has closed below the minimum $1.00 per share requirement for continued inclusion under Listing Rule 5450(a)(1). The letter stated that Nasdaq will provide Anthera a grace period of 180 calendar days, or until June 18, 2013, to regain compliance. To regain compliance, any time before June 18, 2013, the bid price of Anthera's common stock must close at $1.00 per share or more for a minimum of 10 consecutive business days.

---